Optimal primary end point in Phase II trials of immune checkpoint inhibitors for advanced solid cancers: an evolving issue. [electronic resource]

By: Contributor(s): Producer: 20200213Description: 365-368 p. digitalISSN:
  • 1750-7448
Subject(s): Online resources: In: Immunotherapy vol. 11
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Editorial

There are no comments on this title.

to post a comment.